ArticleEuropean journal of cancer (Oxford, England : 1990)2021

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma.

Caroline Robert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.